Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results| (NASDAQ: CRVS) | Delayed: 13.20 -0.73 (5.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.93 | 52 Week High | $17.77 | |||
| Open | $13.76 | 52 Week Low | $9.63 | |||
| Day High | $13.91 | P/E | N/A | |||
| Day Low | $13.15 | EPS | $0.00 | |||
| Volume | 325,115 | |||||

